Targeting HER1/EGFR: a molecular approach to cancer therapy

C Arteaga - Seminars in oncology, 2003 - Elsevier
The varying efficacy and toxicity of traditional cancer therapies has driven the development
of novel target-based agents. Members of the HER (Human Epidermal Receptor) family, in …
被引用次数：353 相关文章

Targeting HER1/EGFR: A molecular approach to cancer therapy

CL Arteaga - Seminars in oncology, 2003 - utsouthwestern.elsevierpure.com
The varying efficacy and toxicity of traditional cancer therapies has driven the development
of novel target-based agents. Members of the HER (Human Epidermal Receptor) family, in …

Targeting HER1/EGFR: a molecular approach to cancer therapy.

C Arteaga - Seminars in Oncology, 2003 - europepmc.org
The varying efficacy and toxicity of traditional cancer therapies has driven the development
of novel target-based agents. Members of the HER (Human Epidermal Receptor) family, in …

[引用][C] Targeting HER1/EGFR: a molecular approach to cancer therapy

C ARTEAGA - Semin Oncol, 2003 - cir.nii.ac.jp
Targeting HER1/EGFR : a molecular approach to cancer therapy | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

[引用][C] Targeting HERI/EGFR: A molecular approach to cancer therapy

C ARTEAGA - Seminars in oncology, 2003 - pascal-francis.inist.fr
Targeting HERI/EGFR: A molecular approach to cancer therapy CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

Targeting HER1/EGFR: a molecular approach to cancer therapy

C Arteaga - Seminars in oncology, 2003 - pubmed.ncbi.nlm.nih.gov
The varying efficacy and toxicity of traditional cancer therapies has driven the development
of novel target-based agents. Members of the HER (Human Epidermal Receptor) family, in …

Targeting HER1/EGFR: a molecular approach to cancer therapy

C Arteaga - Seminars in Oncology, 2003 - infona.pl
The varying efficacy and toxicity of traditional cancer therapies has driven the development
of novel target-based agents. Members of the HER (Human Epidermal Receptor) family, in …

Targeting HER1/EGFR: A molecular approach to cancer therapy

C Arteaga - Seminars in Oncology, 2003 - infona.pl
The varying efficacy and toxicity of traditional cancer therapies has driven the development
of novel target-based agents. Members of the HER (Human Epidermal Receptor) family, in …

[引用][C] Targeting HER1/EGFR: A molecular approach to cancer therapy

C ARTEAGA - Seminars in Oncology, 2003 - cir.nii.ac.jp
Targeting HER1/EGFR: A molecular approach to cancer therapy | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

[引用][C] Targeting HERI/EGFR: A molecular approach to cancer therapy

C ARTEAGA - Seminars in oncology, 2003 - Elsevier